Assyro AI

Orange Book product · Brand (NDA)

TLANDO

TESTOSTERONE UNDECANOATE

Brand (NDA)NDA 208088RX VERITY

At a glance

Mar 28, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

15

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 28, 2022

    4 yr 3 mo ago

  2. Today

  3. Patent 11304960 expires

    Listed drug product patent expiration.

    Jan 08, 2029

    in 2 yr 7 mo

  4. Patent 8778922 expires

    Listed drug product patent expiration.

    Jan 08, 2029

    in 2 yr 7 mo

  5. Patent 8865695 expires

    Listed method-of-use patent (U-1500) expiration.

    Jan 08, 2029

    in 2 yr 7 mo

  6. Patent 10226473 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  7. Patent 10716794 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  8. Patent 11311555 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  9. Patent 11364249 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  10. Patent 11433083 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  11. Patent 9943527 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  12. Patent 9949985 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 30, 2030

    in 4 yr 6 mo

  13. Patent 11559530 expires

    Listed method-of-use patent (U-1500) expiration.

    Nov 28, 2037

    in 11 yr 7 mo

  14. Patent 12310978 expires

    Listed method-of-use patent (U-4194) expiration.

    Feb 21, 2039

    in 12 yr 10 mo

  15. Patent 12011503 expires

    Listed drug product patent expiration.

    Oct 16, 2040

    in 14 yr 6 mo

  16. Patent 12011503 expires

    Listed drug product patent expiration.

    Oct 16, 2040

    in 14 yr 6 mo

  17. Patent 11464735 expires

    Listed drug product patent expiration.

    Apr 28, 2041

    in 15 yr 1 mo

Pharmaceutical detail

Active ingredient

TESTOSTERONE UNDECANOATE

Strength

112.5MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 208088

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (15)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11304960Jan 08, 2029in 2 yr 7 mo
ProductU-1500
8778922Jan 08, 2029in 2 yr 7 mo
ProductU-1500
8865695Jan 08, 2029in 2 yr 7 mo
U-1500
10226473Nov 30, 2030in 4 yr 6 mo
U-1500
10716794Nov 30, 2030in 4 yr 6 mo
U-1500
11311555Nov 30, 2030in 4 yr 6 mo
U-1500
11364249Nov 30, 2030in 4 yr 6 mo
U-1500
11433083Nov 30, 2030in 4 yr 6 mo
U-1500
9943527Nov 30, 2030in 4 yr 6 mo
U-1500
9949985Nov 30, 2030in 4 yr 6 mo
U-1500
11559530Nov 28, 2037in 11 yr 7 mo
U-1500
12310978Feb 21, 2039in 12 yr 10 mo
U-4194
12011503Oct 16, 2040in 14 yr 6 mo
ProductU-3964
12011503Oct 16, 2040in 14 yr 6 mo
ProductU-3965
11464735Apr 28, 2041in 15 yr 1 mo
ProductU-1500
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.